How much funding has DNA Script raised?

DNA Script has raised $466.5M in total funding, most recently a Series C round.

Who are DNA Script's investors?

DNA Script's investors include Illumina Ventures, LSP, Fidelity Management, T. Rowe Price, Baillie Gifford, Columbia Threadneedle Investments.

When was DNA Script founded?

DNA Script was founded in 2014.

Where is DNA Script headquartered?

DNA Script is headquartered in Paris, France.

What industry is DNA Script in?

DNA Script operates in Biotech, Synthetic Biology.

How many employees does DNA Script have?

DNA Script has 51-200 employees.

DNA Script

Revolutionizing biological research with enzymatic DNA synthesis.

Paris, France · Founded 2014 · $466.5M raised

Biotech

Synthetic Biology

Headquarters: Paris
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: dnascript.com
Total Funding: $466.5M
Last Round: $200.0M Series CJan 2022
Rounds: 5

About

DNA Script was created to revolutionize DNA writing with enzymes. Core R&D innovations in enzyme engineering, surface chemistry, and nucleotide chemistry power the SYNTAX DNA printer. This benchtop instrument produces dsDNA and ssDNA for synthetic biology, biopharma, and research, eliminating reliance on external suppliers.

Summary

DNA Script is a Biotech company based in Paris, France, founded in 2014. It has raised $466.5M in total across 5 rounds, most recently a $200.0M Series C round in Jan 2022. Investors include Illumina Ventures, LSP and Fidelity Management.

LinkedIn X (Twitter)